The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women
- PMID: 30255717
- PMCID: PMC6355147
- DOI: 10.1177/0269881118798610
The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women
Abstract
Background/aims: Given high rates of depression and suicide among marginalized women, and increasing calls to integrate trauma-informed biomedical and community-led structural interventions, this study longitudinally examines the potential moderating effect of psychedelic use on the relationship between other illicit drug use and suicide risk.
Methods: Data (2010-2017) were drawn from a community-based, prospective open cohort of marginalized women in Vancouver, Canada. Extended Cox regression analyses examined the moderating effect of psychedelic use on the association between other illicit drug use and incidence of suicidal ideation or attempt over follow-up.
Results: Of 340 women without suicidal ideation or attempt at baseline, 16% ( n=53) reported a first suicidal episode during follow-up, with an incidence density of 4.63 per 100 person-years (95% confidence interval 3.53-6.07). In unadjusted analysis, psychedelic use moderated the relationship between prescription opioid use and suicide risk: among women who did not use psychedelics, prescription opioid use increased the hazard of suicide (hazard ratio 2.91; 95% confidence interval 1.40-6.03) whereas prescription opioid use was not associated with increased suicidal ideation or attempt among those who used psychedelics (hazard ratio 0.69; 95% confidence interval 0.27-1.73) (interaction term p-value: 0.016). The moderating effect of psychedelics remained significant when adjusted for confounders (interaction term p-value: 0.036).
Conclusions: Psychedelic use had a protective moderating effect on the relationship between prescription opioid use and suicide risk. In the context of a severe public health crisis around prescription opioids and lack of addiction services tailored to marginalized women, this study supports calls for innovative, evidence-based and trauma-informed interventions, including further research on the potential benefits of psychedelics.
Keywords: Women; hallucinogens; moderating effect; psychedelics; substance use; suicide prevention.
Conflict of interest statement
Declaration of Conflicting Interests
The authors declare that there is no conflict of interest.
Similar articles
-
Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.BMJ Open. 2017 Sep 21;7(9):e016025. doi: 10.1136/bmjopen-2017-016025. BMJ Open. 2017. PMID: 28939573 Free PMC article.
-
Examining the association between prescription opioid misuse and suicidal behaviors among adolescent high school students in the United States.J Psychiatr Res. 2019 May;112:44-51. doi: 10.1016/j.jpsychires.2019.02.018. Epub 2019 Mar 1. J Psychiatr Res. 2019. PMID: 30852426
-
Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts.J Psychiatr Res. 2017 Sep;92:1-7. doi: 10.1016/j.jpsychires.2017.03.011. Epub 2017 Mar 19. J Psychiatr Res. 2017. PMID: 28364579
-
How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature.Curr Drug Abuse Rev. 2015;8(2):104-10. doi: 10.2174/187447370802150928185302. Curr Drug Abuse Rev. 2015. PMID: 26452451 Review.
-
Association of Psychotic Experiences With Subsequent Risk of Suicidal Ideation, Suicide Attempts, and Suicide Deaths: A Systematic Review and Meta-analysis of Longitudinal Population Studies.JAMA Psychiatry. 2019 Feb 1;76(2):180-189. doi: 10.1001/jamapsychiatry.2018.3514. JAMA Psychiatry. 2019. PMID: 30484818 Free PMC article.
Cited by
-
Using Mindfulness-Based Cognitive Therapy to Prevent Suicide among High Suicide Risk Patients who also Misuse Opioids: A Preliminary Probe of Feasibility and Effectiveness.Int J Ment Health Addict. 2022 Apr 19;21:3721-3734. Int J Ment Health Addict. 2022. PMID: 40129516 Free PMC article.
-
Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.Int J Drug Policy. 2022 Feb;100:103518. doi: 10.1016/j.drugpo.2021.103518. Epub 2021 Nov 7. Int J Drug Policy. 2022. PMID: 34758431 Free PMC article.
-
Psychedelics and Suicide-Related Outcomes: A Systematic Review.J Clin Med. 2025 Feb 20;14(5):1416. doi: 10.3390/jcm14051416. J Clin Med. 2025. PMID: 40094838 Free PMC article. Review.
-
Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms.Am J Ophthalmol Case Rep. 2025 Jun 2;39:102359. doi: 10.1016/j.ajoc.2025.102359. eCollection 2025 Sep. Am J Ophthalmol Case Rep. 2025. PMID: 40535325 Free PMC article.
-
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.Sci Rep. 2022 Oct 10;12(1):16976. doi: 10.1038/s41598-022-18645-3. Sci Rep. 2022. PMID: 36216840 Free PMC article.
References
-
- Alper KR, Lotsof HS, Frenken GM, et al. (1999) Treatment of acute opioid withdrawal with ibogaine. The American Journal on Addictions 8(3): 234–242. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical